North America In Vitro Diagnostics (IVD) Market 2021-2031

North America in vitro diagnostics (IVD) market is projected to grow by 5.6% annually in the forecast period and reach $ 54,000.3 million by end of the year 2031.

North America in vitro diagnostics (IVD) market is projected to grow by 5.6% annually in the forecast period and reach $ 54,000.3 million by 2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, burgeoning demand for automation in diagnostics, the rising development of condition-specific treatment and booming awareness regarding personalized medicines, emergence of minimally invasive and non-invasive diagnostics tools & techniques, the rising healthcare expenditure, and rise in the demand for POC testing. Highlighted with 25 tables and 60 figures, this 131-page report “North America In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America in vitro diagnostics (IVD) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America in vitro diagnostics (IVD) market in every aspect of the classification from perspectives of Product, Technology, Sample Type, Application, End User, and Country.

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Based on Product, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Instruments & Devices o Disposable IVD Devices o Reusable IVD Devices • Reagents & Kits • Software & Services Based on Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Clinical Chemistry • Molecular Diagnostics • Immuno Diagnostics • Hematology • Tissue Diagnostics • Microbiology • Coagulation and Hemostasis • Urinalysis • Other Technologies By Sample Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Blood • Mucus • Urine • Other Sample Types

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Infectious Diseases • Diabetes • Cancer/Oncology • Cardiology • Autoimmune Disease • Nephrology • Drug Testing • HIV/AIDS • Other Applications By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Diagnostic Laboratories • Hospitals and Clinics • Homecare Settings • Point-of-Care (POC) Settings • Other End Users Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Application and End User over the forecast years are also included.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott Laboratories, Inc. Agilent Technologies, Inc. Arkray Inc. Becton, Dickinson and Company Biomerieux SA Bio-Rad Laboratories Inc. Danaher Corporation DiaSorin SpA (Luminex Corporation) Epic Systems Corporation F. Hoffmann-La Roche Ltd. Genpact Limited Grifols SA IBM Corporation Mckesson Corporation Ortho Clinical Diagnostics Inc. Qiagen NV Quest Diagnostics Inc. Quidel Corporation Roche Diagnostics Siemens Healthineers Sysmex Corporation Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents

  • 1 Introduction 7
  • 1.1 Industry Definition and Research Scope 7
  • 1.1.1 Industry Definition 7
  • 1.1.2 Research Scope 8
  • 1.2 Research Methodology 11
  • 1.2.1 Overview of Market Research Methodology 11
  • 1.2.2 Market Assumption 12
  • 1.2.3 Secondary Data 12
  • 1.2.4 Primary Data 12
  • 1.2.5 Data Filtration and Model Design 13
  • 1.2.6 Market Size/Share Estimation 14
  • 1.2.7 Research Limitations 15
  • 1.3 Executive Summary 16
  • 2 Market Overview and Dynamics 19
  • 2.1 Market Size and Forecast 19
  • 2.1.1 Impact of COVID-19 on World Economy 20
  • 2.1.2 Impact of COVID-19 on the Market 24
  • 2.2 Major Growth Drivers 26
  • 2.3 Market Restraints and Challenges 32
  • 2.4 Emerging Opportunities and Market Trends 35
  • 2.5 Porter’s Fiver Forces Analysis 39
  • 3 Segmentation of North America Market by Product 43
  • 3.1 Market Overview by Product 43
  • 3.2 Instruments & Devices 45
  • 3.2.1 Disposable IVD Devices 46
  • 3.2.2 Reusable IVD Devices 47
  • 3.3 Reagents & Kits 48
  • 3.4 Software & Services 49
  • 4 Segmentation of North America Market by Technology 50
  • 4.1 Market Overview by Technology 50
  • 4.2 Clinical Chemistry 52
  • 4.3 Molecular Diagnostics 53
  • 4.4 Immuno Diagnostics 54
  • 4.5 Hematology 55
  • 4.6 Tissue Diagnostics 56
  • 4.7 Microbiology 57
  • 4.8 Coagulation and Hemostasis 58
  • 4.9 Urinalysis 59
  • 4.10 Other Technologies 60
  • 5 Segmentation of North America Market by Sample Type 61
  • 5.1 Market Overview by Sample Type 61
  • 5.2 Blood 63
  • 5.3 Mucus 64
  • 5.4 Urine 65
  • 5.5 Other Sample Types 66
  • 6 Segmentation of North America Market by Application 67
  • 6.1 Market Overview by Application 67
  • 6.2 Infectious Diseases 69
  • 6.3 Diabetes 79
  • 6.4 Cancer/Oncology 80
  • 6.5 Cardiology 81
  • 6.6 Autoimmune Disease 82
  • 6.7 Nephrology 83
  • 6.8 Drug Testing 84
  • 6.9 HIV/AIDS 85
  • 6.10 Other Applications 86
  • 7 Segmentation of North America Market by End User 87
  • 7.1 Market Overview by End User 87
  • 7.2 Diagnostic Laboratories 89
  • 7.3 Hospitals and Clinics 90
  • 7.4 Homecare Settings 91
  • 7.5 Point-of-Care (POC) Settings 92
  • 7.6 Other End Users 93
  • 8 North America Market 2021-2031 by Country 94
  • 8.1 Overview of North America Market 94
  • 8.2 U.S. 97
  • 8.3 Canada 100
  • 8.4 Mexico 102
  • 9 Competitive Landscape 104
  • 9.1 Overview of Key Vendors 104
  • 9.2 New Product Launch, Partnership, Investment, and M&A 107
  • 9.3 Company Profiles 108
  • Abbott Laboratories, Inc. 108
  • Agilent Technologies, Inc. 110
  • Arkray Inc. 111
  • Becton, Dickinson and Company 112
  • Biomerieux SA 113
  • Bio-Rad Laboratories Inc. 114
  • Danaher Corporation 115
  • DiaSorin SpA (Luminex Corporation) 116
  • Epic Systems Corporation 117
  • F. Hoffmann-La Roche Ltd. 118
  • Genpact Limited 119
  • Grifols SA 120
  • IBM Corporation 121
  • Mckesson Corporation 122
  • Ortho Clinical Diagnostics Inc. 123
  • Qiagen NV 124
  • Quest Diagnostics Inc. 125
  • Quidel Corporation 126
  • Roche Diagnostics 127
  • Siemens Healthineers 128
  • Sysmex Corporation 129
  • Thermo Fisher Scientific Inc. 130
  • RELATED REPORTS 131

List of Figures:

Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. North America In Vitro Diagnostics Market, 2021-2031, $ mn 19
Figure 5. Impact of COVID-19 on Business 24
Figure 6. Primary Drivers and Impact Factors of North America In Vitro Diagnostics Market 26
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million 29
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 30
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 30
Figure 10. Primary Restraints and Impact Factors of North America In Vitro Diagnostics Market 32
Figure 11. Investment Opportunity Analysis 36
Figure 12. Porter’s Fiver Forces Analysis of North America In Vitro Diagnostics Market 39
Figure 13. Breakdown of North America In Vitro Diagnostics Market by Product, 2021-2031, % of Revenue 44
Figure 14. North America Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%) 44
Figure 15. North America In Vitro Diagnostics Market by Product: Instruments & Devices, 2021-2031, $ mn 45
Figure 16. North America In Vitro Diagnostics Market by Instruments & Devices: Disposable IVD Devices, 2021-2031, $ mn 46
Figure 17. North America In Vitro Diagnostics Market by Instruments & Devices: Reusable IVD Devices, 2021-2031, $ mn 47
Figure 18. North America In Vitro Diagnostics Market by Product: Reagents & Kits, 2021-2031, $ mn 48
Figure 19. North America In Vitro Diagnostics Market by Product: Software & Services, 2021-2031, $ mn 49
Figure 20. Breakdown of North America In Vitro Diagnostics Market by Technology, 2021-2031, % of Sales Revenue 51
Figure 21. North America Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%) 51
Figure 22. North America In Vitro Diagnostics Market by Technology: Clinical Chemistry, 2021-2031, $ mn 52
Figure 23. North America In Vitro Diagnostics Market by Technology: Molecular Diagnostics, 2021-2031, $ mn 53
Figure 24. North America In Vitro Diagnostics Market by Technology: Immuno Diagnostics, 2021-2031, $ mn 54
Figure 25. North America In Vitro Diagnostics Market by Technology: Hematology, 2021-2031, $ mn 55
Figure 26. North America In Vitro Diagnostics Market by Technology: Tissue Diagnostics, 2021-2031, $ mn 56
Figure 27. North America In Vitro Diagnostics Market by Technology: Microbiology, 2021-2031, $ mn 57
Figure 28. North America In Vitro Diagnostics Market by Technology: Coagulation and Hemostasis, 2021-2031, $ mn 58
Figure 29. North America In Vitro Diagnostics Market by Technology: Urinalysis, 2021-2031, $ mn 59
Figure 30. North America In Vitro Diagnostics Market by Technology: Other Technologies, 2021-2031, $ mn 60
Figure 31. Breakdown of North America In Vitro Diagnostics Market by Sample Type, 2021-2031, % of Sales Revenue 62
Figure 32. North America Addressable Market Cap in 2022-2031 by Sample Type, Value ($ mn) and Share (%) 62
Figure 33. North America In Vitro Diagnostics Market by Sample Type: Blood, 2021-2031, $ mn 63
Figure 34. North America In Vitro Diagnostics Market by Sample Type: Mucus, 2021-2031, $ mn 64
Figure 35. North America In Vitro Diagnostics Market by Sample Type: Urine, 2021-2031, $ mn 65
Figure 36. North America In Vitro Diagnostics Market by Sample Type: Other Sample Types, 2021-2031, $ mn 66
Figure 37. Breakdown of North America In Vitro Diagnostics Market by Application, 2021-2031, % of Revenue 68
Figure 38. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 68
Figure 39. North America In Vitro Diagnostics Market by Application: Infectious Diseases, 2021-2031, $ mn 69
Figure 40. North America In Vitro Diagnostics Market by Application: Diabetes, 2021-2031, $ mn 79
Figure 41. North America In Vitro Diagnostics Market by Application: Cancer/Oncology, 2021-2031, $ mn 80
Figure 42. North America In Vitro Diagnostics Market by Application: Cardiology, 2021-2031, $ mn 81
Figure 43. North America In Vitro Diagnostics Market by Application: Autoimmune Disease, 2021-2031, $ mn 82
Figure 44. North America In Vitro Diagnostics Market by Application: Nephrology, 2021-2031, $ mn 83
Figure 45. North America In Vitro Diagnostics Market by Application: Drug Testing, 2021-2031, $ mn 84
Figure 46. North America In Vitro Diagnostics Market by Application: HIV/AIDS, 2021-2031, $ mn 85
Figure 47. North America In Vitro Diagnostics Market by Application: Other Applications, 2021-2031, $ mn 86
Figure 48. Breakdown of North America In Vitro Diagnostics Market by End User, 2021-2031, % of Revenue 88
Figure 49. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 88
Figure 50. North America In Vitro Diagnostics Market by End User: Diagnostic Laboratories, 2021-2031, $ mn 89
Figure 51. North America In Vitro Diagnostics Market by End User: Hospitals and Clinics, 2021-2031, $ mn 90
Figure 52. North America In Vitro Diagnostics Market by End User: Homecare Settings, 2021-2031, $ mn 91
Figure 53. North America In Vitro Diagnostics Market by End User: Point-of-Care (POC) Settings, 2021-2031, $ mn 92
Figure 54. North America In Vitro Diagnostics Market by End User: Other End Users, 2021-2031, $ mn 93
Figure 55. Breakdown of North America In Vitro Diagnostics Market by Country, 2021 and 2031, % of Revenue 95
Figure 56. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 96
Figure 57. U.S. In Vitro Diagnostics Market, 2021-2031, $ mn 98
Figure 58. Canada In Vitro Diagnostics Market, 2021-2031, $ mn 100
Figure 59. In Vitro Diagnostics Market in Mexico, 2021-2031, $ mn 102
Figure 60. Growth Stage of North America In Vitro Diagnostics Industry over the Forecast Period 104

List of Tables:

Table 1. Snapshot of North America In Vitro Diagnostics Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Economic Outlook, 2021-2023 22
Table 4. World Health Spending by Region, $ bn, 2013-2020 31
Table 5. Main Product Trends and Market Opportunities in North America In Vitro Diagnostics Market 35
Table 6. North America In Vitro Diagnostics Market by Product, 2021-2031, $ mn 43
Table 7. North America In Vitro Diagnostics Market: Instruments & Devices by Type, 2021-2031, $ mn 45
Table 8. North America In Vitro Diagnostics Market by Technology, 2021-2031, $ mn 50
Table 9. North America In Vitro Diagnostics Market by Sample Type, 2021-2031, $ mn 61
Table 10. North America In Vitro Diagnostics Market by Application, 2021-2031, $ mn 67
Table 11. Commercially Available COVID-19 Diagnostic Tests Approved in 2021-2022 70
Table 12. North America In Vitro Diagnostics Market by End User, 2021-2031, $ mn 87
Table 13. North America In Vitro Diagnostics Market by Country, 2021-2031, $ mn 95
Table 14. U.S. In Vitro Diagnostics Market by Product, 2021-2031, $ mn 99
Table 15. U.S. In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 99
Table 16. U.S. In Vitro Diagnostics Market by End User, 2021-2031, $ mn 99
Table 17. Canada In Vitro Diagnostics Market by Product, 2021-2031, $ mn 101
Table 18. Canada In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 101
Table 19. Canada In Vitro Diagnostics Market by End User, 2021-2031, $ mn 101
Table 20. Mexico In Vitro Diagnostics Market by Product, 2021-2031, $ mn 103
Table 21. Mexico In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 103
Table 22. Mexico In Vitro Diagnostics Market by End User, 2021-2031, $ mn 103
Table 23. Abbott Laboratories, Inc.: Company Snapshot 108
Table 24. Abbott Laboratories, Inc.: Business Segmentation 109
Table 25. Abbott Laboratories, Inc.: Product Portfolio 109
Logo

North America In Vitro Diagnostics (IVD) Market 2021-2031

Contact usWe are friendly and approachable, give us a call.